Speakers

Stewart is EVP and Site Head at the Deeside facility, and is responsible for leading Sterling’s bioconjugation and ADC services. His main focus is to grow capacity and capabilities within this area of the business, as well as integrate Sterling’s High Potency API offering within its ADC services.

Bringing more than 25 years of industry experience to Sterling, Stewart previously managed sites in the UK and US for companies including Rhodia, Shasun, Piramal and Thermo Fisher. He joined Sterling in 2021 from CMAC, University of Strathclyde, where he managed multiple technology industrial collaborative projects within advanced pharmaceutical research, manufacturing and training.

Presentation Title:

View company profile